Paxalisib (GDC-0084)
NVGN-0084-201
Phase 2 small_molecule completed
Quick answer
Paxalisib (GDC-0084) for Glioblastoma, Adult is a Phase 2 program (small_molecule) at KAZIA THERAPEUTICS LTD with 1 ClinicalTrials.gov record(s).
Program details
- Company
- KAZIA THERAPEUTICS LTD
- Indication
- Glioblastoma, Adult
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed